Resumen

ASCANO ORTEGA, Alicia Carmen. Complex lesions in neuroinfectious diabetic foot and its treatment with Heberprot-P^®. Rev Cubana Angiol Cir Vasc [online]. 2020, vol.21, n.3  Epub 22-Ene-2021. ISSN 1682-0037.

The global prevalence of diabetic foot ranges from 6.4%. Amputation in people with diabetes is 10 to 20 times more common than in non-diabetics and every 30 seconds somewhere in the world someone suffers the amputation of a lower limb as a result of diabetes. Heberprot-P® constitutes a product indicated and registered by Cuba for the treatment of patients with neuropathic and neuroischemic ulcers of the diabetic foot, which in this case results in a complex injury, in advanced state and with high risk of amputation (Wagner 4). This study aimed to present a case that demonstrates the effectiveness of healing from a complex diabetic foot wound treated with Heberprot-P®. It was the case of a 47-year-old male diabetic type 1 patient who was admitted at "Dr. Mario Muñoz Monroy" Hospital in Matanzas province, in 2017, with the diagnosis of neuroinfectious diabetic foot, and lesions in the first finger and plantar base of all fingers (grade 4, according to Wagner's classification). It was conducted a disarticulation of the first toe and a plantar necrectomy. Subsequently, after metabolic control and sepsis, 21 infiltrations of Heberprot-P® (75 g) were made over a period of 45 days. Finally, an epithelialization of approximately 95% of the wound was achieved. In this way, the effectiveness in healing complex lesions of the diabetic foot was shown through the use of Heberprot-P®.

Palabras clave : Diabetic foot; healing; Heberprot-P®.

        · resumen en Español     · texto en Español     · Español ( pdf )